Background: Some people who suffer an upper gastrointestinal bleed or perforation die. The mortality rate was estimated at 12% in studies published before 1997, but a systematic survey of more recent ...

Please provide your email address to receive an email when new articles are posted on . Evidence for metoclopramide use in upper GI bleeding is very low, with few published trial data. Existing data ...

A risk-based screening strategy shows high efficacy and significant reductions in cost in the detection of upper gastrointestinal cancers compared with conventional universal screening, results from a ...

Symptoms of GI bleeding include stomach pain, vomiting blood, or having black, tarry stool. Peptic ulcers are the leading cause of upper GI bleeding, while diverticular disease is the most common ...

Phase II trial of transarterial chemoembolization followed by sintilimab (anti-PD-1), oxaliplatin, and S-1 combined with either trastuzumab (HER-2 positive) or apatinib (HER-2 negative) as first-line ...

Upper GI mucosal damage was tied to a 76% higher risk of subsequent Parkinson's disease. The retrospective study followed GI patients for nearly 15 years. The findings support literature suggesting ...

The recent appointment further strengthens King’s College Hospital London’s multidisciplinary approach to advanced ...